Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy

Antiviral Research

Volumn 65, Issue 1, 2005, Pages 23-34

  Okuse, Chiaki ^a   Rinaudo, Jo Ann ^a   Farrar, Kristine ^a   Wells, Frances ^a   Korba, Brent E ^a  

^a GEORGETOWN UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Combination antiviral therapy; Cytokines; HCV replicon; Hepatitis C Virus; Interferon

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERFERON; OMEGA INTERFERON; RIBAVIRIN; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; ARTICLE; CELL ACTIVITY; CELL CULTURE; CELL LINE; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENCY; DRUG POTENTIATION; DRUG SELECTIVITY; EXPERIMENT; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IN VITRO STUDY; IN VIVO STUDY; INHIBITION KINETICS; KINETICS; MONOTHERAPY; PRIORITY JOURNAL; REPLICON; VIRUS INHIBITION; VIRUS REPLICATION;

ANTIVIRAL AGENTS; CELL LINE, TUMOR; CYTOKINES; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; HEPACIVIRUS; HUMANS; INTERFERON TYPE I; INTERFERON TYPE II; REPLICON; RIBAVIRIN; VIRAL PROTEINS; VIRUS REPLICATION;

HEPATITIS C VIRUS;

EID: 11844269964     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.antiviral.2004.09.002     Document Type: Article

References (35)

1. H.J. Alter, and L.B. Seeff Recovery, persistence, and sequelae in hepatitis C virus infection: a perspective on long-term outcome Semin. Liver Dis. 20 2000 17 35
2. Y. Asahina, N. Izumi, M. Uchihara, O. Noguchi, K. Tsuchiya, K. Hamano, N. Kanazawa, J. Itakura, S. Miyake, and T. Sakai A potent antiviral effect on hepatitis C viral dynamics in serum and peripheral blood mononuclear cells during combination therapy with high-dose daily interferon alfa plus ribavirin and intravenous twice-daily treatment with interferon beta Hepatology 34 2001 377 384
3. M.S. Belen'kii, and R. Schinazi A method for the analysis of combination therapies with statistical analysis Antivir. Res. 25 1994 11 18
4. C.B. Bigger, K.M. Brasky, and R.E. Lanford DNA microarray analysis of chimpanzee liver during acute resolving hepatitis C infection J. Virol. 75 2001 7059 7066
5. K.J. Blight, A.A. Kolykhalov, and C.M. Rice Efficient initiation of HCV RNA replication in cell culture Science 290 2000 1972 1974
6. I.W. Cheney, V.C. Lai, W. Zhong, T. Brodhag, S. Dempsey, C. Lim, Z. Hong, J.Y. Lau, and R.C. Tam Comparative analysis of anti-hepatitis C virus activity and gene expression mediated by alpha, beta, and gamma interferons J. Virol. 76 2002 1148 1154
7. G.L. Davis, R. Esteban-Mur, V.K. Rustgi, J. Hoefs, S.C. Gordon, C. Trepo, M.L. Shiffman, S. Zeuzen, A. Craxi, M.H. Ling, and J.K. Albecht Interferon alfa-2b alone or in combination with ribavirin for the treatment of relapse of chronic hepatitis C N. Engl. J. Med. 339 1998 1493 1499
8. Der, S.D., Zhou, A., Williams, B.R.G., Silverman, R.H., 1998. Identification of genes differentially regulated by interferon α, β, or γ using oligonucleotide arrays. Proc. Natl. Acad. Sci. USA. 95, 15623-15628.
9. D. Dhanak, K.J. Duffy, V.K. Johnston, J. Lin-Goerke, M. Darcy, A.N. Shaw, B. Gu, C. Silverman, A.T. Gates, M.R. Nonnemacher, D.L. Earnshaw, D.J. Casper, A. Kaura, A. Baker, C. Greenwood, L.L. Gutshall, D. Maley, A. DelVecchio, R. Macarron, G.A. Hofmann, Z. Alnoah, H.Y. Cheng, G. Chan, S. Khandekar, R.M. Keenan, and R.T. Sarisky Identification and biological characterization of heterocyclic inhibitors of the hepatitis C virus RNA-dependent RNA polymerase J. Biol. Chem. 277 2002 38322 38327
10. G. Dusheiko, J. Main, H. Thomas, O. Reichard, C. Lee, A. Dhillon, S. Rassam, A. Fryden, H. Reesink, M. Bassendine, G. Norkrans, T. Cuypers, N. Lelie, P. Telfer, J. Watson, C. Weegink, P. Sillikens, and O. Weiland Ribavirin treatment for patients with chronic hepatitis C: results of a placebo-controlled study J. Hepatol. 25 1996 591 598
11. I. Flores, T.M. Mariano, and S. Pestka Human interferon omega (omega) binds to the alpha-beta receptor J. Biol. Chem. 266 1991 19875 19877
12. M. Frese, T. Pirtschmann, D. Moradpour, O. Haller, and R. Bartenschlager Interferon-α inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway J. Gen. Virol. 75 2001 723 733
13. M. Frese, V. Schwarzle, K. Barth, N. Krieger, V. Lohmann, S. Mihm, O. Haller, and R. Bartenschlager Interferon-gamma inhibits replication of subgenomic and genomic hepatitis C virus RNAs Hepatology 35 2002 694 703
14. J.-T. Gao, V.V. Bichko, and C. Seeger Effect of alpha interferon on the hepatitis C virus replicon J. Virol. 75 2001 8516 8523
15. S. Goodbourn, L. Didcock, and R.E. Randall Interferons: cell signaling, immune modulation, antiviral response and virus countermeasures J. Gen. Virol. 81 2000 2341 2364
16. R. Hauptmann, and P. Swetly A novel class of human Type I interferons Nucl. Acids Res. 13 1985 4739 4749
17. N. Horiike, H. Hino, Y. Tanaka, H. Miyaoka, S. Miki, S. Yamashita, B. Matsuura, Y. Kubo, Y. Ikeda, S.M. Akbar, T. Masumoto, K. Michitaka, and M. Onji Combination therapy with interferon alpha and beta to chronic hepatitis C Oncol. Rep. 10 2003 157 161
18. K. Katayama, A. Kasahara, Y. Sasaki, T. Kashiwagi, M. Naito, M. Masuzawa, M. Katoh, H. Yoshihara, T. Kamada, T. Mukuda, T. Hijioka, M. Hori, and N. Hayashi Immunological response to interferon-gamma priming prior to interferon-alpha treatment in refractory chronic hepatitis C in relation to viral clearance J. Viral Hepat. 8 2001 180 185
19. B.E. Korba In vitro evaluation of combination therapies against hepatitis B virus replication Antivir. Res. 29 1996 49 51
20. B.E. Korba, and J.L. Gerin Use of a standardized cell culture assay to determine activities of nucleoside analogs against hepatitis B virus replication Antivir. Res. 19 1992 55 70
21. R.E. Lanford, B. Guerra, H. Lee, D.R. Averett, B. Pfeiffer, D. Chavez, L. Notvall, and C. Bigger Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons J. Virol. 77 2003 1092 1104
22. G.M. Lauer, and B.D. Walker Hepatitis C virus infection N. Engl. J. Med. 345 2001 41 52
23. M. Llinas-Brunet, M.D. Bailey, G. Bolger, C. Brochu, A.M. Faucher, J.M. Ferland, M. Garneau, E. Ghiro, V. Gorys, C. Grand-Maitre, T. Halmos, N. Lapeyre-Paquette, F. Liard, M. Poirier, M. Rheaume, Y.S. Tsantrizos, and D. Lamarre Structure-activity study on a novel series of macrocyclic inhibitors of the hepatitis C virus NS3 protease leading to the discovery of BILN2061 J. Med. Chem. 47 2004 605 608
24. V. Lohmann, F. Korner, J.O. Koch, U. Herian, L. Theilmann, and R. Bartenschlager Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line Science 285 1999 110 113
25. J.G. McHutchinson, S.C. Gordon, E.R. Schiff, M.L. Shiffman, W.M. Lee, V.K. Rustgi, Z.D. Goodman, M.H. Ling, S. Cort, and J.K. Albrecht Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C N. Engl. J. Med. 339 1998 1485 1492
26. J. Pflugheber, B. Fredericksen, R. Sumpter Jr., C. Wang, F. Ware, D.L. Sodore, and M. Gale Jr. Regulation of PKR and IRF-1 during hepatitis C virus RNA replication Proc. Natl. Acad. Sci. U.S.A. 99 2002 4650 4655
27. T. Poynard, V. Ratziu, Y. Benhamou, P. Opolon, P. Cacoub, and P. Bedossa Natural history of HCV infection Best Pract. Rec. Clin. Gastroenterol. 14 2000 211 228
28. Y. Saito, V. Escuret, D. Durantel, F. Zoulim, R.F. Schinazi, and L.A. Agrofoglio Synthesis of 1,2,3-triazolo-carbanucleoside analogues of ribavirin targeting an HCV in replicon Bioorg. Med. Chem. 11 2003 3633 3639
29. G.R. Stark, I.M. Kerr, B.R. Williams, R.H. Silverman, and R.D. Schreiber How cells respond to interferons Annu. Rev. Biochem. 67 1998 227 264
30. A.I. Su, J.P. Pezacki, L. Wodicka, A.D. Brideau, L. Supekova, R. Thimme, S. Wieland, J. Bukh, R.H. Purcell, P.G. Schultz, and F.V. Chisari Genomic analysis of the host response to hepatitis C virus infection PNAS U.S.A. 99 2002 15669 15674
31. Y. Tanabe, N. Sakamoto, N. Enomoto, M. Kurosaki, E. Ueda, S. Maekawa, T. Yamashiro, M. Nakagawa, C.H. Chen, N. Kanazawa, S. Kakinuma, and M. Watanabe Synergistic inhibition of intracellular hepatitis C virus replication by combination of ribavirin and interferon-alpha J. Infect. Dis. 189 2004 1129 1139
32. R.C. Tam, B. Pai, J. Bard, C. Lim, D.R. Averett, U.T. Phan, and T. Milovanovic Ribavirin polarizes human T cell responses towards a type 1 cytokine profile J. Hepatol. 30 1999 376 382
33. R.C. Tam, C. Lim, and B. Pai Contact hypersensitivity responses following ribavirin treatment in vivo are influenced by type 1 cytokine polarization, regulation of IL-10 expression, and costimulatory signaling J. Immunol. 163 1999 3709 3717
34. H. Watanabe, K. Iwata, T. Sohda, and S. Sakisaka Interferon beta induction/interferon alpha therapy in patients with interferon-resistant chronic hepatitis C Hepatol. Res. 24 2002 355 360
35. S. Zhou, R. Liu, B.M. Baroudy, B.A. Malcolm, and G.R. Reyes The effect of ribavirin and IMPDH inhibitors on hepatitis C virus subgenomic replicon RNA Virology 310 2003 333 342